These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30472762)

  • 21. Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond.
    Libby P
    J Am Coll Cardiol; 2017 Oct; 70(18):2278-2289. PubMed ID: 29073957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis.
    Nijsten T; Spuls PI
    Br J Dermatol; 2008 Jul; 159(1):257-8. PubMed ID: 18489593
    [No Abstract]   [Full Text] [Related]  

  • 23. Targeting IL-1β in the Treatment of Atherosclerosis.
    Mai W; Liao Y
    Front Immunol; 2020; 11():589654. PubMed ID: 33362770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inflammation and atherosclerosis – last piece of the puzzle has fallen into place].
    Jonasson L; Hansson G
    Lakartidningen; 2017 Oct; 114():. PubMed ID: 29292899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate: the best choice for second-line maintenance treatment in active Crohn's disease?
    Grimaldi C
    Gastroenterol Clin Biol; 2009 Jan; 33(1 Pt 1):21-2. PubMed ID: 18977624
    [No Abstract]   [Full Text] [Related]  

  • 26. From clinical observations to molecular mechanisms and back to patients: the successful circuit of the CANTOS study.
    Lembo G
    Cardiovasc Res; 2018 Jan; 114(1):e3-e5. PubMed ID: 29293914
    [No Abstract]   [Full Text] [Related]  

  • 27. Atherosclerosis: perspectives of anti-inflammatory therapy.
    Nasonov EL; Popkova TV
    Ter Arkh; 2018 May; 90(5):4-12. PubMed ID: 30701884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of multicentric reticulohistiocytosis with adalimumab, minocycline, methotrexate.
    Yeter KC; Arkfeld DG
    Int J Rheum Dis; 2013 Feb; 16(1):105-6. PubMed ID: 23441782
    [No Abstract]   [Full Text] [Related]  

  • 29. Critical roles of inflammation in atherosclerosis.
    Moriya J
    J Cardiol; 2019 Jan; 73(1):22-27. PubMed ID: 29907363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized controlled trials in maintenance of remission in Crohn's disease.
    D'Incà R; Caccaro R
    Rev Recent Clin Trials; 2012 Nov; 7(4):270-83. PubMed ID: 23092231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview.
    Nidorf SM; Thompson PL
    Clin Ther; 2019 Jan; 41(1):41-48. PubMed ID: 30591286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting the Immune System in Atherosclerosis: JACC State-of-the-Art Review.
    Zhao TX; Mallat Z
    J Am Coll Cardiol; 2019 Apr; 73(13):1691-1706. PubMed ID: 30947923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colchicine: an affordable anti-inflammatory agent for atherosclerosis.
    Thompson PL; Nidorf SM
    Curr Opin Lipidol; 2018 Dec; 29(6):467-473. PubMed ID: 30320614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality Differences Associated With Treatment Responses in CANTOS and FOURIER: Insights and Implications.
    Ridker PM
    Circulation; 2018 Apr; 137(17):1763-1766. PubMed ID: 29273581
    [No Abstract]   [Full Text] [Related]  

  • 35. The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials.
    Adamstein NH; MacFadyen JG; Rose LM; Glynn RJ; Dey AK; Libby P; Tabas IA; Mehta NN; Ridker PM
    Eur Heart J; 2021 Mar; 42(9):896-903. PubMed ID: 33417682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammation in atherosclerotic cardiovascular disease.
    Shah PK; Lecis D
    F1000Res; 2019; 8():. PubMed ID: 31448091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS).
    Ridker PM; Libby P; MacFadyen JG; Thuren T; Ballantyne C; Fonseca F; Koenig W; Shimokawa H; Everett BM; Glynn RJ
    Eur Heart J; 2018 Oct; 39(38):3499-3507. PubMed ID: 30165610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A perspective on targeting inflammation and cytokine actions in atherosclerosis.
    Chan YH; Ramji DP
    Future Med Chem; 2020 Apr; 12(7):613-626. PubMed ID: 32175772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Takayasu arteritis and NYHA III/IV idiopathic cardiomiopathy: tocilizumab proves effective and safe.
    Schiavon F; Cuffaro S; Ometto F; Mojoli M; Ramonda R
    Joint Bone Spine; 2014 May; 81(3):278-9. PubMed ID: 24388783
    [No Abstract]   [Full Text] [Related]  

  • 40. Should self-destructive behavior affect a patient's access to scarce medical resources?
    Yang CS; Kroumpouzos G; Bercovitch L
    J Am Acad Dermatol; 2015 Jul; 73(1):154-7. PubMed ID: 26089050
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.